The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.

The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35151800

about

Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.Dietary Vitamin K and Association with Hepatic Vitamin K Status in a Yup'ik Study Population from Southwestern Alaska.

P2860

Q38980072-907C99D8-1FD3-4248-A16F-480A8A472C30 Q47592472-86AB8CA7-E14D-4EBE-A049-5CA98774EA44

P2860

The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35151800

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

The influence of alcoholic liv ...... hout hepatocellular carcinoma.

@ast

The influence of alcoholic liv ...... hout hepatocellular carcinoma.

@en

type

label

The influence of alcoholic liv ...... hout hepatocellular carcinoma.

@ast

The influence of alcoholic liv ...... hout hepatocellular carcinoma.

@en

prefLabel

The influence of alcoholic liv ...... hout hepatocellular carcinoma.

@ast

The influence of alcoholic liv ...... hout hepatocellular carcinoma.

@en

P1433

Q35151800-53314E25-3C27-4615-B172-BE135A541897

P1476

Q35151800-22B619E8-6FC6-46A0-8F4C-C06D471FCFDC

P2093

Q35151800-13F0CA3F-B5F9-4154-8D13-393D29211BF4

Q35151800-19150E2D-F16C-464F-BA53-170BE31BE5A6

Q35151800-3A607838-1F89-4989-9598-59F95F2D450C

Q35151800-3AB7C3FC-6BCE-4BB7-85F3-AD1F3640CDAA

Q35151800-5D8866E0-1A61-450D-9EDD-356D9C0C97C9

Q35151800-75472F94-DC1A-46B8-B283-068457047ABE

Q35151800-9101D794-707E-4026-9C17-5D8A3BA248B6

Q35151800-9204DEF8-3CE1-449D-AD5F-7B72D56CB929

Q35151800-B82BC133-B421-49CE-85F5-99A429A0285F

Q35151800-EBE9A83F-9F3F-4990-A577-4FD11DEBBBBE

P2860

Q35151800-042CBC86-5C54-43F0-8475-F302A47AE450

Q35151800-08844691-7906-48A4-908F-BC40C67EDB5B

Q35151800-13007F12-6344-4FB7-960B-48CF994D1088

Q35151800-20E151EF-698B-41F0-A1EA-1290B2CF7A91

Q35151800-3605B86C-DB60-4B84-AB72-9C881E60C890

Q35151800-4B65746B-DAAD-43A5-BA94-FED555322D39

Q35151800-5D0293CB-9D5A-4959-BCB3-9BFB4FD23F01

Q35151800-8158CF6A-7EA4-408D-A7B3-87B8A84E12B9

Q35151800-A08913A3-7E31-4990-8E40-B18D7FA55E12

Q35151800-AE487A7A-6BB2-4327-B08A-E90C5D319B88

P304

Q35151800-6184D07F-A584-429F-AB98-0238D4345ECC

P31

Q35151800-0390960A-7982-499F-890E-8F15D7DD1318

P356

Q35151800-A9BDBBF3-F008-41C2-B3A6-C116D90D1509

P433

Q35151800-4B6F1126-F896-46D9-93AC-628DA8654C69

P478

Q35151800-ACB42825-F873-4048-85F0-65A9F14A1EBC

P577

Q35151800-D2C3D24D-A61F-47BA-A2A4-15C0BB87CD1B

P5875

Q35151800-0AF89209-E476-4BE0-8AAC-BFF8AF764E3E

P698

Q35151800-2626A828-FF53-4363-A00D-42A9F55BE873

P932

Q35151800-A21D7FCA-A9C5-40CA-8BAA-FADE1A5E2228

P356

P1433

P1476

The influence of alcoholic liv ...... hout hepatocellular carcinoma.

@en

P2093

Beom Jae Lee

http://www.w3.org/2001/XMLSchema#string

Hyung Joon Yim

http://www.w3.org/2001/XMLSchema#string

Jae Seon Kim

http://www.w3.org/2001/XMLSchema#string

Ji Hoon Kim

http://www.w3.org/2001/XMLSchema#string

Jong Eun Yeon

http://www.w3.org/2001/XMLSchema#string

Jong Jae Park

http://www.w3.org/2001/XMLSchema#string

Keun Hee Kang

http://www.w3.org/2001/XMLSchema#string

Kwan Soo Byun

http://www.w3.org/2001/XMLSchema#string

Seong Hee Kang

http://www.w3.org/2001/XMLSchema#string

Yeon Seok Seo

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamins K and D status in stages 3-5 chronic kidney disease

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

Plasma des-gamma-carboxyprothrombin in the early stage of hepatocellular carcinoma

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status.

PIVKA-II-producing advanced gastric cancer.

Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.

Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.

Recent advances in hepatic vitamin K metabolism and function.

gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin.

P304

224-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5009/GNL14047

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269170673

http://www.w3.org/2001/XMLSchema#string

P698

25473073

http://www.w3.org/2001/XMLSchema#string

P932

4351030

http://www.w3.org/2001/XMLSchema#string